The role of autophagy in neurodegenerative disease
暂无分享,去创建一个
[1] M. Farrer,et al. DCTN1 mutations in Perry syndrome , 2009, Nature Genetics.
[2] S. Wing,et al. Ataxin-3 Deubiquitination Is Coupled to Parkin Ubiquitination via E2 Ubiquitin-conjugating Enzyme* , 2011, The Journal of Biological Chemistry.
[3] S Shoji-Kawata,et al. [Identification of a candidate therapeutic autophagy-inducing peptide]. , 2015, Seikagaku. The Journal of Japanese Biochemical Society.
[4] T. Bird,et al. Intracellular accumulation of amyloidogenic fragments of amyloid-beta precursor protein in neurons with Niemann-Pick type C defects is associated with endosomal abnormalities. , 2004, The American journal of pathology.
[5] M. Goedert,et al. Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy , 2012, Brain : a journal of neurology.
[6] P. Alifano,et al. Functional Characterization of Rab7 Mutant Proteins Associated with Charcot-Marie-Tooth Type 2B Disease , 2008, The Journal of Neuroscience.
[7] Y. Itoyama,et al. Loss of ALS2/Alsin Exacerbates Motor Dysfunction in a SOD1H46R-Expressing Mouse ALS Model by Disturbing Endolysosomal Trafficking , 2010, PloS one.
[8] H. Eldar-Finkelman,et al. Inhibition of Glycogen Synthase Kinase-3 Ameliorates β-Amyloid Pathology and Restores Lysosomal Acidification and Mammalian Target of Rapamycin Activity in the Alzheimer Disease Mouse Model , 2012, The Journal of Biological Chemistry.
[9] S. Hadano,et al. Defective relocalization of ALS2/alsin missense mutants to Rac1‐induced macropinosomes accounts for loss of their cellular function and leads to disturbed amphisome formation , 2011, FEBS letters.
[10] F. Platt,et al. Common and Uncommon Pathogenic Cascades in Lysosomal Storage Diseases* , 2010, The Journal of Biological Chemistry.
[11] S. Ajroud‐Driss,et al. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. , 2011, Archives of neurology.
[12] A. Cuervo,et al. Altered lipid content inhibits autophagic vesicular fusion , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[13] P. Saftig,et al. Sphingolipid Storage Affects Autophagic Metabolism of the Amyloid Precursor Protein and Promotes Aβ Generation , 2011, The Journal of Neuroscience.
[14] C. Steward. Neurological aspects of osteopetrosis , 2003, Neuropathology and applied neurobiology.
[15] D. Standaert,et al. Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity , 2008, Molecular Brain.
[16] P. Maher,et al. Chemical modification of the multitarget neuroprotective compound fisetin. , 2012, Journal of medicinal chemistry.
[17] D. Hailey,et al. Autophagy termination and lysosome reformation regulated by mTOR , 2010, Nature.
[18] Mauro Piacentini,et al. The dynamic interaction of AMBRA1 with the dynein motor complex regulates mammalian autophagy , 2010, The Journal of cell biology.
[19] D. Sabatini,et al. mTOR signaling at a glance , 2009, Journal of Cell Science.
[20] J. Simon,et al. AMP-activated Protein Kinase Signaling Activation by Resveratrol Modulates Amyloid-β Peptide Metabolism* , 2010, The Journal of Biological Chemistry.
[21] J. Terzic,et al. Ubiquitin-independent function of optineurin in autophagic clearance of protein aggregates , 2013, Journal of Cell Science.
[22] V. Marshansky. The V-ATPase a2-subunit as a putative endosomal pH-sensor. , 2007, Biochemical Society transactions.
[23] J. Jankovic,et al. Resveratrol-Activated AMPK/SIRT1/Autophagy in Cellular Models of Parkinson's Disease , 2011, Neurosignals.
[24] C. Glabe. Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer’s disease , 2001, Journal of Molecular Neuroscience.
[25] Shailendra Giri,et al. The role of AMPK in psychosine mediated effects on oligodendrocytes and astrocytes: implication for Krabbe Disease , 2008, Journal of neurochemistry.
[26] H. Soininen,et al. AMP‐activated protein kinase: a potential player in Alzheimer’s disease , 2011, Journal of neurochemistry.
[27] D. Rubinsztein,et al. Novel targets for Huntington's disease in an mTOR-independent autophagy pathway. , 2008, Nature chemical biology.
[28] W. Le,et al. Altered macroautophagy in the spinal cord of SOD1 mutant mice , 2008, Autophagy.
[29] G. Skibinski. Mutations in the ESCRTIII endosomal complex protein CHMP2B associate with frontotemporal dementia , 2005 .
[30] M. Ohno,et al. Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits. , 2011, Brain : a journal of neurology.
[31] Ralph A. Nixon,et al. Extensive Involvement of Autophagy in Alzheimer Disease: An Immuno-Electron Microscopy Study , 2005, Journal of neuropathology and experimental neurology.
[32] M. Kabani,et al. Hsc70 Protein Interaction with Soluble and Fibrillar α-Synuclein* , 2011, The Journal of Biological Chemistry.
[33] S. Muallem,et al. TRP-ML1 Regulates Lysosomal pH and Acidic Lysosomal Lipid Hydrolytic Activity* , 2006, Journal of Biological Chemistry.
[34] L. Mucke,et al. Antiamyloidogenic and Neuroprotective Functions of Cathepsin B: Implications for Alzheimer's Disease , 2006, Neuron.
[35] V. Malhotra,et al. Non-autophagic roles of autophagy-related proteins , 2013, EMBO reports.
[36] E. Masliah,et al. PGC-1α Rescues Huntington’s Disease Proteotoxicity by Preventing Oxidative Stress and Promoting TFEB Function , 2012, Science Translational Medicine.
[37] D. Rubinsztein,et al. Huntington’s disease: degradation of mutant huntingtin by autophagy , 2008, The FEBS journal.
[38] Shengdi Chen,et al. Roles of the Drosophila LRRK2 homolog in Rab7-dependent lysosomal positioning. , 2012, Human molecular genetics.
[39] Steve D. M. Brown,et al. Dynein mutations impair autophagic clearance of aggregate-prone proteins , 2005, Nature Genetics.
[40] J. Flanagan,et al. Identification and characterization of pharmacological chaperones to correct enzyme deficiencies in lysosomal storage disorders. , 2011, Assay and drug development technologies.
[41] Angela D. Wilkins,et al. Identification of a candidate therapeutic autophagy-inducing peptide , 2013, Nature.
[42] B. Hyman,et al. Distinct Roles In Vivo for the Ubiquitin–Proteasome System and the Autophagy–Lysosomal Pathway in the Degradation of α-Synuclein , 2011, The Journal of Neuroscience.
[43] B. Bahr,et al. Protective Effects of Positive Lysosomal Modulation in Alzheimer's Disease Transgenic Mouse Models , 2011, PloS one.
[44] M. DiFiglia,et al. The Role of Chaperone-Mediated Autophagy in Huntingtin Degradation , 2012, PloS one.
[45] D. Rubinsztein,et al. Laforin, the most common protein mutated in Lafora disease, regulates autophagy , 2010, Human molecular genetics.
[46] D. Sulzer,et al. Autophagy in neurons: a review. , 2002, Histology and histopathology.
[47] T. Yamashima. Hsp70.1 and related lysosomal factors for necrotic neuronal death , 2012, Journal of neurochemistry.
[48] Dimitri Krainc,et al. The selective macroautophagic degradation of aggregated proteins requires the PI3P-binding protein Alfy. , 2010, Molecular cell.
[49] G. Siciliano,et al. The role of autophagy: what can be learned from the genetic forms of amyotrophic lateral sclerosis. , 2010, CNS & neurological disorders drug targets.
[50] T. Stauber,et al. A role for chloride transport in lysosomal protein degradation , 2010, Autophagy.
[51] D. Sulzer,et al. CARGO RECOGNITION FAILURE IS RESPONSIBLE FOR INEFFICIENT AUTOPHAGY IN HUNTINGTON’S DISEASE , 2010, Nature Neuroscience.
[52] N. Nukina,et al. Serine 403 phosphorylation of p62/SQSTM1 regulates selective autophagic clearance of ubiquitinated proteins. , 2011, Molecular cell.
[53] M. Cookson,et al. Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease? , 2012, BMC Medicine.
[54] D. Sabatini,et al. Rapamycin inhibits mTORC1, but not completely , 2009, Autophagy.
[55] G. Siciliano,et al. Protein clearing pathways in ALS. , 2011, Archives italiennes de biologie.
[56] M. Cookson,et al. Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synuclein. , 2009, The American journal of pathology.
[57] A. Cuervo,et al. Trehalose ameliorates dopaminergic and tau pathology in parkin deleted/tau overexpressing mice through autophagy activation , 2010, Neurobiology of Disease.
[58] K. Tsai,et al. Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43 , 2012, Proceedings of the National Academy of Sciences.
[59] G. Small,et al. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[60] D. Sulzer,et al. Neuronal pigmented autophagic vacuoles: lipofuscin, neuromelanin, and ceroid as macroautophagic responses during aging and disease , 2008, Journal of neurochemistry.
[61] D. Price,et al. Motor Neuron Disease Occurring in a Mutant Dynactin Mouse Model Is Characterized by Defects in Vesicular Trafficking , 2008, The Journal of Neuroscience.
[62] C. Manzoni. LRRK2 and autophagy: a common pathway for disease. , 2012, Biochemical Society transactions.
[63] Jayanta Debnath,et al. Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease , 2010, PloS one.
[64] D. Rubinsztein,et al. Autophagy modulation as a potential therapeutic target for diverse diseases , 2012, Nature Reviews Drug Discovery.
[65] Jeffrey N. Savas,et al. Acetylation Targets Mutant Huntingtin to Autophagosomes for Degradation , 2009, Cell.
[66] P. Andersen,et al. A novel optineurin truncating mutation and three glaucoma-associated missense variants in patients with familial amyotrophic lateral sclerosis in Germany , 2013, Neurobiology of Aging.
[67] Jin-A Lee,et al. Inhibition of Autophagy Induction Delays Neuronal Cell Loss Caused by Dysfunctional ESCRT-III in Frontotemporal Dementia , 2009, The Journal of Neuroscience.
[68] Don W. Cleveland,et al. Prion-like spread of protein aggregates in neurodegeneration , 2012 .
[69] A. Goffinet,et al. Reelin Signals through Phosphatidylinositol 3-Kinase and Akt To Control Cortical Development and through mTor To Regulate Dendritic Growth , 2007, Molecular and Cellular Biology.
[70] C. Bauvy,et al. PP2A blockade inhibits autophagy and causes intraneuronal accumulation of ubiquitinated proteins , 2013, Neurobiology of Aging.
[71] B. Davidson,et al. Clarifying lysosomal storage diseases , 2011, Trends in Neurosciences.
[72] S. Slaugenhaupt,et al. Macroautophagy is defective in mucolipin-1-deficient mouse neurons , 2010, Neurobiology of Disease.
[73] R. Nixon,et al. Autophagy and neuronal cell death in neurological disorders. , 2012, Cold Spring Harbor perspectives in biology.
[74] T. Irie,et al. Effects of cyclodextrin in two patients with Niemann-Pick Type C disease. , 2013, Molecular genetics and metabolism.
[75] O. Arancio,et al. Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease. , 2008, The Journal of clinical investigation.
[76] F. Platt,et al. Substrate reduction therapy , 2008, Acta paediatrica.
[77] A. Ballabio,et al. Transcriptional Activation of Lysosomal Exocytosis Promotes Cellular Clearance , 2011, Developmental cell.
[78] Ralph A. Nixon,et al. Autophagy failure in Alzheimer's disease—locating the primary defect , 2011, Neurobiology of Disease.
[79] Atsushi Tanaka,et al. PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin , 2010, PLoS biology.
[80] K. Abe,et al. Increased autophagy in transgenic mice with a G93A mutant SOD1 gene , 2007, Brain Research.
[81] Ralph A. Nixon,et al. Autophagy Induction and Autophagosome Clearance in Neurons: Relationship to Autophagic Pathology in Alzheimer's Disease , 2008, The Journal of Neuroscience.
[82] T. Noda,et al. Rubicon and PLEKHM1 Negatively Regulate the Endocytic/Autophagic Pathway via a Novel Rab7-binding Domain , 2010, Molecular biology of the cell.
[83] T. Noda,et al. An Atg4B mutant hampers the lipidation of LC3 paralogues and causes defects in autophagosome closure. , 2008, Molecular biology of the cell.
[84] E. Skordalakes,et al. Disease mutations in Rab7 result in unregulated nucleotide exchange and inappropriate activation , 2009, Human molecular genetics.
[85] J. Buxbaum,et al. Lysosomal Dysfunction in a Mouse Model of Sandhoff Disease Leads to Accumulation of Ganglioside-Bound Amyloid-β Peptide , 2012, The Journal of Neuroscience.
[86] F. Reggiori. Autophagy: New Questions from Recent Answers , 2012, ISRN molecular biology.
[87] D. Piwnica-Worms,et al. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease , 2009, The Journal of cell biology.
[88] A. Consiglio,et al. Interplay of LRRK2 with chaperone-mediated autophagy , 2013, Nature Neuroscience.
[89] G. Logroscino,et al. Current epidemiological approaches to the metabolic-cognitive syndrome. , 2012, Journal of Alzheimer's disease : JAD.
[90] P. Maher,et al. Fisetin Lowers Methylglyoxal Dependent Protein Glycation and Limits the Complications of Diabetes , 2011, PloS one.
[91] D. Rubinsztein,et al. Rapamycin alleviates toxicity of different aggregate-prone proteins. , 2006, Human molecular genetics.
[92] Guido Kroemer,et al. Lysosomes and autophagy in cell death control , 2005, Nature Reviews Cancer.
[93] Alzheimer's disease beta-amyloid peptides are released in association with exosomes. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[94] A. Laties,et al. Stimulation of the D5 dopamine receptor acidifies the lysosomal pH of retinal pigmented epithelial cells and decreases accumulation of autofluorescent photoreceptor debris , 2012, Journal of neurochemistry.
[95] D. Rubinsztein,et al. Autophagosome Precursor Maturation Requires Homotypic Fusion , 2011, Cell.
[96] E. Masliah,et al. Regulation of Amyloid Precursor Protein Processing by the Beclin 1 Complex , 2010, PloS one.
[97] Sooyeon Lee,et al. Lysosomal Proteolysis Inhibition Selectively Disrupts Axonal Transport of Degradative Organelles and Causes an Alzheimer's-Like Axonal Dystrophy , 2011, The Journal of Neuroscience.
[98] R. Nixon,et al. Neuronal macroautophagy: from development to degeneration. , 2006, Molecular aspects of medicine.
[99] R. Takahashi,et al. Clinicopathologic study on an ALS family with a heterozygous E478G optineurin mutation , 2011, Acta Neuropathologica.
[100] T. Melia,et al. Modulating macroautophagy: a neuronal perspective. , 2012, Future medicinal chemistry.
[101] R. Jiao,et al. Drosophila Histone Deacetylase 6 Protects Dopaminergic Neurons against α-Synuclein Toxicity by Promoting Inclusion Formation , 2010, Molecular biology of the cell.
[102] Ryan J Kast,et al. Selective histone deacetylase (HDAC) inhibition imparts beneficial effects in Huntington's disease mice: implications for the ubiquitin-proteasomal and autophagy systems. , 2012, Human molecular genetics.
[103] R. Mahley,et al. Reactivity of apolipoprotein E4 and amyloid beta peptide: lysosomal stability and neurodegeneration. , 2006, The Journal of biological chemistry.
[104] Jeffrey P. MacKeigan,et al. Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy , 2009, Cell.
[105] D. Corey,et al. Regulation of TFEB and V-ATPases by mTORC1 , 2011, The EMBO journal.
[106] M. Colombo,et al. Rab7 is required for the normal progression of the autophagic pathway in mammalian cells , 2004, Journal of Cell Science.
[107] C. Duve,et al. Functions of lysosomes. , 1966, Annual review of physiology.
[108] D. Chuang,et al. Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model , 2008, Neuroscience.
[109] J. Taylor,et al. VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD , 2010, Autophagy.
[110] A. Cuervo,et al. Restoration of chaperone-mediated autophagy in aging liver improves cellular maintenance and hepatic function , 2008, Nature Network Boston.
[111] Jian Wang,et al. Effect of Trehalose on PC12 Cells Overexpressing Wild-Type or A53T Mutant α-synuclein , 2012, Neurochemical Research.
[112] S. Gygi,et al. Network organization of the human autophagy system , 2010, Nature.
[113] Steve D. M. Brown,et al. Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease , 2010, Human molecular genetics.
[114] I. Bezprozvanny. The rise and fall of Dimebon. , 2010, Drug news & perspectives.
[115] Jun Liu,et al. Curcumin Ameliorates the Neurodegenerative Pathology in A53T α-synuclein Cell Model of Parkinson’s Disease Through the Downregulation of mTOR/p70S6K Signaling and the Recovery of Macroautophagy , 2013, Journal of Neuroimmune Pharmacology.
[116] M. MacDonald,et al. Autophagy Is Disrupted in a Knock-in Mouse Model of Juvenile Neuronal Ceroid Lipofuscinosis* , 2006, Journal of Biological Chemistry.
[117] C. Sutherland,et al. Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling , 2010, Proceedings of the National Academy of Sciences.
[118] J. Perrard,et al. An Alternative Splicing Variant in Clcn7 –/– Mice Prevents Osteopetrosis but Not Neural and Retinal Degeneration , 2011, Veterinary pathology.
[119] K. Marder,et al. RAB7L1 Interacts with LRRK2 to Modify Intraneuronal Protein Sorting and Parkinson’s Disease Risk , 2013, Neuron.
[120] Y. Ioannou,et al. Cyclodextrin Induces Calcium-Dependent Lysosomal Exocytosis , 2010, PloS one.
[121] S. Tooze,et al. Kinase-Inactivated ULK Proteins Inhibit Autophagy via Their Conserved C-Terminal Domains Using an Atg13-Independent Mechanism , 2008, Molecular and Cellular Biology.
[122] David M. Sabatini,et al. The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1 , 2008, Science.
[123] E. Mandelkow,et al. Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing. , 2009, Human molecular genetics.
[124] G. Kroemer,et al. Lysosomal membrane permeabilization in cell death , 2008, Oncogene.
[125] Y. Ohsumi,et al. Hierarchy of Atg proteins in pre‐autophagosomal structure organization , 2007, Genes to cells : devoted to molecular & cellular mechanisms.
[126] Liang Li,et al. Rapamycin treatment augments motor neuron degeneration in SOD1G93A mouse model of amyotrophic lateral sclerosis , 2011, Autophagy.
[127] S. Kozma,et al. Selective pharmacogenetic inhibition of mammalian target of Rapamycin complex I (mTORC1) blocks long-term synaptic plasticity and memory storage , 2011, Proceedings of the National Academy of Sciences.
[128] D. Rubinsztein,et al. Lithium induces autophagy by inhibiting inositol monophosphatase , 2005, The Journal of cell biology.
[129] L. Sundstrom,et al. Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer’s disease model , 2010, Journal of Clinical Neuroscience.
[130] P. Conn,et al. Pharmacological chaperones for misfolded gonadotropin-releasing hormone receptors. , 2011, Advances in pharmacology.
[131] D. Rubinsztein,et al. Autophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 3 , 2009, Brain : a journal of neurology.
[132] A. Zylicz,et al. Hsp70 stabilizes lysosomes and reverts Niemann–Pick disease-associated lysosomal pathology , 2010, Nature.
[133] G. Petsko,et al. Latrepirdine stimulates autophagy and reduces accumulation of α-synuclein in cells and in mouse brain , 2012, Molecular Psychiatry.
[134] E. Bézard,et al. Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration , 2012, Proceedings of the National Academy of Sciences.
[135] Masaaki Komatsu,et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice , 2006, Nature.
[136] C. Bendotti,et al. Treatment with lithium carbonate does not improve disease progression in two different strains of SOD1 mutant mice , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[137] R. Neve,et al. Down syndrome fibroblast model of Alzheimer-related endosome pathology: accelerated endocytosis promotes late endocytic defects. , 2008, The American journal of pathology.
[138] Xuejun Jiang,et al. Distinct autophagosomal-lysosomal fusion mechanism revealed by thapsigargin-induced autophagy arrest. , 2011, Molecular cell.
[139] H. Serve,et al. Ubiquitination and selective autophagy , 2012, Cell Death and Differentiation.
[140] P. Saftig,et al. Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function , 2009, Nature Reviews Molecular Cell Biology.
[141] D. Walsh,et al. Macroautophagy Is Not Directly Involved in the Metabolism of Amyloid Precursor Protein* , 2010, The Journal of Biological Chemistry.
[142] O. Forlenza,et al. Does Lithium Prevent Alzheimer’s Disease? , 2012, Drugs & Aging.
[143] Guido Kroemer,et al. Autophagy and the integrated stress response. , 2010, Molecular cell.
[144] J. Loeffler,et al. Histone deacetylase inhibitors: therapeutic agents and research tools for deciphering motor neuron diseases. , 2008, Current medicinal chemistry.
[145] A. Lieberman,et al. Impaired proteolysis underlies autophagic dysfunction in Niemann-Pick type C disease. , 2012, Human molecular genetics.
[146] A. Caccamo,et al. Molecular Interplay between Mammalian Target of Rapamycin (mTOR), Amyloid-β, and Tau , 2010, The Journal of Biological Chemistry.
[147] Steve D. M. Brown,et al. α-Synuclein impairs macroautophagy: implications for Parkinson's disease , 2010 .
[148] G. Bernardi,et al. Inhibition of the Striatal Specific Phosphodiesterase PDE10A Ameliorates Striatal and Cortical Pathology in R6/2 Mouse Model of Huntington's Disease , 2010, PloS one.
[149] Y. Hui,et al. Calcium overload is associated with lipofuscin formation in human retinal pigment epithelial cells fed with photoreceptor outer segments , 2011, Eye.
[150] A. d’Azzo,et al. Neuraminidase 1 is a negative regulator of lysosomal exocytosis. , 2008, Developmental cell.
[151] Cahir J. O'Kane,et al. Lysosomal positioning coordinates cellular nutrient responses , 2011, Nature Cell Biology.
[152] A. Brice,et al. What genetics tells us about the causes and mechanisms of Parkinson's disease. , 2011, Physiological reviews.
[153] Hideyuki Okano,et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice , 2006, Nature.
[154] N. Gray,et al. Leucine-rich repeat kinase 2 inhibitors: a patent review (2006 – 2011) , 2012, Expert opinion on therapeutic patents.
[155] L. Gan,et al. Cystatin C-Cathepsin B Axis Regulates Amyloid Beta Levels and Associated Neuronal Deficits in an Animal Model of Alzheimer's Disease , 2008, Neuron.
[156] A. Cuervo,et al. Chaperone-mediated autophagy: a unique way to enter the lysosome world. , 2012, Trends in cell biology.
[157] F. van Leuven,et al. Glycogen Synthase Kinase 3 Inhibition Promotes Lysosomal Biogenesis and Autophagic Degradation of the Amyloid-β Precursor Protein , 2012, Molecular and Cellular Biology.
[158] R. Burke,et al. Akt Suppresses Retrograde Degeneration of Dopaminergic Axons by Inhibition of Macroautophagy , 2011, The Journal of Neuroscience.
[159] S. Schmidt,et al. Presenilin Mutations in Familial Alzheimer Disease and Transgenic Mouse Models Accelerate Neuronal Lysosomal Pathology , 2004, Journal of neuropathology and experimental neurology.
[160] P. Hollenbeck. Products of endocytosis and autophagy are retrieved from axons by regulated retrograde organelle transport , 1993, The Journal of cell biology.
[161] B T Hyman,et al. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. , 2000, The American journal of pathology.
[162] Peter T. Lansbury,et al. Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy , 2004, Science.
[163] Alexei Degterev,et al. Regulation of Intracellular Accumulation of Mutant Huntingtin by Beclin 1* , 2006, Journal of Biological Chemistry.
[164] Suresh Sharma,et al. Behavioral alterations in rotenone model of Parkinson's disease: Attenuation by co-treatment of centrophenoxine , 2008, Brain Research.
[165] Sooyeon Lee,et al. Autophagy failure in Alzheimer's disease and the role of defective lysosomal acidification , 2013, The European journal of neuroscience.
[166] D. Rubinsztein,et al. Autophagic substrate clearance requires activity of the syntaxin-5 SNARE complex , 2011, Journal of Cell Science.
[167] A. Pestronk,et al. Mutations in the tail domain of DYNC1H1 cause dominant spinal muscular atrophy , 2012, Neurology.
[168] Gabriele Siciliano,et al. Lithium delays progression of amyotrophic lateral sclerosis , 2008, Proceedings of the National Academy of Sciences.
[169] Takeshi Noda,et al. A ubiquitin-like system mediates protein lipidation , 2000, Nature.
[170] S. Sasaki. Autophagy in Spinal Cord Motor Neurons in Sporadic Amyotrophic Lateral Sclerosis , 2011, Journal of neuropathology and experimental neurology.
[171] J. Neefjes,et al. Neuronal ceroid lipofuscinosis protein CLN3 interacts with motor proteins and modifies location of late endosomal compartments , 2012, Cellular and Molecular Life Sciences.
[172] T. P. Neufeld,et al. Regulation of TORC1 by Rag GTPases in nutrient response , 2008, Nature Cell Biology.
[173] A. Schober,et al. Pten ablation in adult dopaminergic neurons is neuroprotective in Parkinson's disease models , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[174] C. Pignata,et al. New strategies for the treatment of lysosomal storage diseases (review). , 2013, International journal of molecular medicine.
[175] D. Ory,et al. Chronic Cyclodextrin Treatment of Murine Niemann-Pick C Disease Ameliorates Neuronal Cholesterol and Glycosphingolipid Storage and Disease Progression , 2009, PloS one.
[176] M. Beal,et al. Neuroprotection by cyclodextrin in cell and mouse models of Alzheimer disease , 2012, The Journal of experimental medicine.
[177] Nina Raben,et al. Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease , 2013, EMBO molecular medicine.
[178] E. Brown,et al. Lysosomal exocytosis is impaired in mucolipidosis type IV. , 2006, Molecular genetics and metabolism.
[179] K. Lim,et al. Jcb: Report , 2022 .
[180] A. Cuervo,et al. Lipophagy: Connecting Autophagy and Lipid Metabolism , 2012, International journal of cell biology.
[181] P. Saftig,et al. Sensitivity to Lysosome-Dependent Cell Death Is Directly Regulated by Lysosomal Cholesterol Content , 2012, PloS one.
[182] Fabienne C. Fiesel,et al. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1 , 2010, Nature Cell Biology.
[183] A. Lehesjoki,et al. Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis. , 2006, Brain : a journal of neurology.
[184] C. Lusk,et al. mTOR dysfunction contributes to vacuolar pathology and weakness in valosin-containing protein associated inclusion body myopathy. , 2013, Human molecular genetics.
[185] P. Verkade,et al. Alzheimer's disease beta-amyloid peptides are released in association with exosomes. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[186] N. Mizushima,et al. Two ubiquitin-like conjugation systems essential for autophagy. , 2004, Seminars in cell & developmental biology.
[187] N. Mizushima,et al. The role of the Atg1/ULK1 complex in autophagy regulation. , 2010, Current opinion in cell biology.
[188] I. Zs.-Nagy,et al. Gerontopsychological studies using NAI ('Nürnberger Alters-Inventar') on patients with organic psychosyndrome (DSM III, Category 1) treated with centrophenoxine in a double blind, comparative, randomized clinical trial. , 1989, Archives of gerontology and geriatrics.
[189] Y. Igarashi,et al. Sphingolipid-modulated Exosome Secretion Promotes Clearance of Amyloid-β by Microglia , 2012, The Journal of Biological Chemistry.
[190] S. Maeda,et al. Adaptive responses to alloxan‐induced mild oxidative stress ameliorate certain tauopathy phenotypes , 2012, Aging cell.
[191] David Park,et al. Abberant α-Synuclein Confers Toxicity to Neurons in Part through Inhibition of Chaperone-Mediated Autophagy , 2009, PloS one.
[192] Gino Laberge,et al. Involvement of kinase PKC-zeta in the p62/p62(P392L)-driven activation of NF-κB in human osteoclasts. , 2013, Biochimica et biophysica acta.
[193] Courtney A Miller,et al. Inhibitors of Class 1 Histone Deacetylases Reverse Contextual Memory Deficits in a Mouse Model of Alzheimer's Disease , 2010, Neuropsychopharmacology.
[194] G. Churchill,et al. Leucine-rich repeat kinase 2 regulates autophagy through a calcium-dependent pathway involving NAADP , 2011, Human molecular genetics.
[195] M. Glogauer,et al. Osteopetrosis Mutation R444L Causes Endoplasmic Reticulum Retention and Misprocessing of Vacuolar H+-ATPase a3 Subunit* , 2012, The Journal of Biological Chemistry.
[196] Keiji Tanaka,et al. Inhibition of autophagy prevents hippocampal pyramidal neuron death after hypoxic-ischemic injury. , 2008, The American journal of pathology.
[197] Anders Björklund,et al. TFEB-mediated autophagy rescues midbrain dopamine neurons from α-synuclein toxicity , 2013, Proceedings of the National Academy of Sciences.
[198] Jeremy N. Skepper,et al. α-Synuclein Is Degraded by Both Autophagy and the Proteasome* , 2003, Journal of Biological Chemistry.
[199] D. Westaway,et al. Lysosomal Proteolysis and Autophagy Require Presenilin 1 and Are Disrupted by Alzheimer-Related PS1 Mutations , 2010, Cell.
[200] R. Sidman,et al. CNS expression of glucocerebrosidase corrects α-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy , 2011, Proceedings of the National Academy of Sciences.
[201] G. Bjørkøy,et al. FYCO1 is a Rab7 effector that binds to LC3 and PI3P to mediate microtubule plus end–directed vesicle transport , 2010, The Journal of cell biology.
[202] Janel O. Johnson,et al. α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.
[203] D. Rubinsztein,et al. Autophagy and Aging , 2011, Cell.
[204] C. Peters,et al. Participation of autophagy in storage of lysosomes in neurons from mouse models of neuronal ceroid-lipofuscinoses (Batten disease). , 2005, The American journal of pathology.
[205] W. Macklin,et al. Akt Signals through the Mammalian Target of Rapamycin Pathway to Regulate CNS Myelination , 2009, The Journal of Neuroscience.
[206] Sebastian A. Wagner,et al. Phosphorylation of the Autophagy Receptor Optineurin Restricts Salmonella Growth , 2011, Science.
[207] R. Aebersold,et al. Endolysosomal sorting of ubiquitylated caveolin-1 is regulated by VCP and UBXD1 and impaired by VCP disease mutations , 2011, Nature Cell Biology.
[208] Simon C Watkins,et al. Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death. , 2007, The American journal of pathology.
[209] I. Ferrer,et al. Chaperone-mediated autophagy markers in Parkinson disease brains. , 2010, Archives of neurology.
[210] A. Isaacs,et al. Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease , 2007, The Journal of cell biology.
[211] Andrea Ballabio,et al. A block of autophagy in lysosomal storage disorders. , 2008, Human molecular genetics.
[212] K. Öllinger,et al. Regulation of apoptosis-associated lysosomal membrane permeabilization , 2010, Apoptosis.
[213] A. Fersht,et al. In vivo activities of GroEL minichaperones. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[214] D. Sabatini,et al. Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids , 2010, Cell.
[215] M. Vila,et al. Pathogenic Lysosomal Depletion in Parkinson's Disease , 2010, The Journal of Neuroscience.
[216] W. Westbroek,et al. Exploring the link between glucocerebrosidase mutations and parkinsonism. , 2011, Trends in molecular medicine.
[217] M. Gearing,et al. Regulation of Neuronal Survival Factor MEF2D by Chaperone-Mediated Autophagy , 2009, Science.
[218] T. Noda,et al. Dynein-dependent movement of autophagosomes mediates efficient encounters with lysosomes. , 2008, Cell structure and function.
[219] E. Masliah,et al. Beclin 1 Gene Transfer Activates Autophagy and Ameliorates the Neurodegenerative Pathology in α-Synuclein Models of Parkinson's and Lewy Body Diseases , 2009, The Journal of Neuroscience.
[220] D. Rubinsztein,et al. Trehalose, a Novel mTOR-independent Autophagy Enhancer, Accelerates the Clearance of Mutant Huntingtin and α-Synuclein* , 2007, Journal of Biological Chemistry.
[221] Francesco Scaravilli,et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease , 2004, Nature Genetics.
[222] L. Greene,et al. Expression of A53T Mutant But Not Wild-Type α-Synuclein in PC12 Cells Induces Alterations of the Ubiquitin-Dependent Degradation System, Loss of Dopamine Release, and Autophagic Cell Death , 2001, The Journal of Neuroscience.
[223] R. Nixon. Niemann-Pick Type C disease and Alzheimer's disease: the APP-endosome connection fattens up. , 2004, The American journal of pathology.
[224] D. Rubinsztein,et al. Mechanisms of Autophagosome Biogenesis , 2012, Current Biology.
[225] H. Stenmark,et al. How do ESCRT proteins control autophagy? , 2009, Journal of Cell Science.
[226] L. Shang,et al. AMPK and mTOR coordinate the regulation of Ulk1 and mammalian autophagy initiation , 2011, Autophagy.
[227] Peter Schwartz,et al. Ambra1 regulates autophagy and development of the nervous system , 2007, Nature.
[228] Raeann L. Carrier,et al. Metformin therapy in a transgenic mouse model of Huntington's disease , 2007, Neuroscience Letters.
[229] A. Koeppen,et al. Overexpression of the autophagic beclin-1 protein clears mutant ataxin-3 and alleviates Machado-Joseph disease. , 2011, Brain : a journal of neurology.
[230] M. Paccalin,et al. mTOR/p70S6k signalling alteration by Aβ exposure as well as in APP‐PS1 transgenic models and in patients with Alzheimer's disease , 2005, Journal of neurochemistry.
[231] K. Qin,et al. Rapamycin Delays Disease Onset and Prevents PrP Plaque Deposition in a Mouse Model of Gerstmann–Sträussler–Scheinker Disease , 2012, The Journal of Neuroscience.
[232] V. Deretic. Autophagy in infection. , 2010, Current opinion in cell biology.